Superoxide dismutase therapy for myocardial ischemia

Area of Science:

• Cardiovascular Research
• Free Radical Biology
• Ischemia-Reperfusion Injury

Background:

• Reperfusion of ischemic myocardium generates oxygen-derived free radicals.
• Three distinct injury levels occur: lethal arrhythmias, stunning (recoverable contractile defect), and infarction (irreversible cell death).

Purpose of the Study:

• To investigate the role of free radicals in different levels of myocardial injury during reperfusion.
• To evaluate the efficacy of antioxidants, iron chelators, and xanthine oxidase inhibitors in mitigating these injuries.

Main Methods:

• Utilized animal models (dog, rat, rabbit) subjected to varying periods of ischemia and reperfusion.
• Administered antioxidants such as superoxide dismutase (SOD) and catalase, iron chelators, and xanthine oxidase inhibitors.
• Assessed arrhythmias, myocardial contractility (stunning), and infarct size using various measurement techniques.

Main Results:

• Antioxidants and iron chelators reduced arrhythmias. Xanthine oxidase inhibitors were as effective as SOD, implicating xanthine oxidase as a radical source.
• SOD plus catalase reduced stunning in various models, but not when administered alone or in xanthine oxidase-deficient rabbits.
• Histological studies indicated that SOD interfered with infarct size assessment; no scavengers definitively limited infarction.

Conclusions:

• Free radicals contribute significantly to arrhythmias and stunning during myocardial reperfusion.
• While antioxidants can mitigate early-stage injuries, they do not appear to prevent irreversible cell death (infarction).
• Further research is needed to understand the precise mechanisms and potential therapeutic targets for limiting infarction.